Tafenoquine and Primaquine in Colostrum and Breast Milk

Stopped Local EC requested that the arms of study be submitted as separate protocols so they could respond to the different risk of each arm. In response investigators have withdrawn this protocol and begun separate submissions, starting with NCT06191458.

Conditions

• Healthy Lactating Women

Interventions

• DRUG: Primaquine
• DRUG: Tafenoquine

Sponsor

University of Oxford

Collaborators

• [object Object]